The future of medical cannabis research and its place in clinical practice with Dr Dedi Meiri

May 19, 2020 by Community newsdesk
Read on for article
Join Dr Dedi Meiri, from the Laboratory of Cancer Biology and Cannabinoid Research at the Technion, as he shares his current research into cannabis for various medical applications.

Dedi will be interviewed by Adam Miller, Founder and Board member at the Medical Cannabis Council and Head of Strategic Accounts at MediPharm Labs – MediPharm Labs are specialists in cannabis extraction and purification.

Date: Wednesday, 20 May
Time: 7pm – 8pm* (Syd / Melb) – * 12pm – 1pm (Israel)
LIVE on ZOOM and FACEBOOK

Dr. Meiri is among the world’s leading scientists dedicated to studying and understanding the very real healing properties of one of the world’s oldest medicinal plants, cannabis – including how it might help in the fight against COVID-19.Cannabis, was first prescribed by the name, ‘Ma’ in 2700 BCE by Chinese healers. What these ancient healers didn’t know about cannabis, is that there are 144 unique strains of phytocannabinoids, aside from the more common CBD and THC strains.

Dr. Meiri and his team have been diligently working on isolating and categorising these 144 individual cannabinoid strains, quite simply so that their healing potential can be further understood.

Comments

One Response to “The future of medical cannabis research and its place in clinical practice with Dr Dedi Meiri”
  1. Graham David Pearl says:

    I am very interested in Medicinal Cannabis.

Speak Your Mind

Comments received without a full name will not be considered
Email addresses are NEVER published! All comments are moderated. J-Wire will publish considered comments by people who provide a real name and email address. Comments that are abusive, rude, defamatory or which contain offensive language will not be published


    Rules on posting comments